UNSPSC 51282531: Cefazolin benzathine

This classification denotes a cephalosporin antibiotic C16H20N2.C14H14N8O4S3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BJN67HUZ04, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-((1h-tetrazol-1-ylacetyl)amino)-, (6r-trans)-, compd. with n,n'-bis(phenylmethyl)-1,2-ethanediamine (2:1), but more generally known as cefazolin benzathine, which bears US NIH Compound Identifier 71300925.

Most nations, for tariff and trade purposes, schedule cefazolin benzathine under HS 29419000 and SITC 54139. As of Q4 2014, CEFAZOLIN BENZATHINE remains US FDA's Preferred Term for this commodity. SMILES: CC1NNC(S1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)CN4CNNN4)SC2)C(=O)O.C1CCC(CC1)CNCCNCC2CCCCC2.

UNSPSC 51282531 Cefazolin benzathine is a Commodity code that encompasses pharmaceutical products including antibiotics and over-the-counter medications procured by state and local health agencies, fire departments, and cooperative purchasing alliances. The code covers generic multi-source pharmaceuticals, emergency medical supplies, and controlled substances used in community health programs and first-response operations. State and local issuing bodies procuring under this code include county health departments, city fire departments, state health and human services agencies, and multi-state cooperative purchasing organizations. Recent opportunities show procurement of naloxone for opioid reversal, medical and first aid supplies for emergency response, and generic pharmaceuticals through cooperative contracting vehicles that aggregate demand across multiple jurisdictions.

Activity under this code spans Florida, Texas, Minnesota, and Oregon, with representation from county-level health authorities, municipal fire departments, and regional cooperative purchasing alliances. Recent representative solicitations include Seminole County, Florida's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually (IFB60459723LAS, response due July 26, 2023); the City of Tampa Fire Department's IFB for 169 line items of medical and first aid supplies totaling an estimated $700,000 with a certified Small Local Business Enterprise set-aside and 5 percent bid discount (26P00145, response due March 13, 2026); the Minnesota Multistate Cooperative Purchasing Alliance's RFP to establish contracts for generic multi-source pharmaceuticals and OTC products distributed across state and local facilities in Minnesota and Oregon (S1070000015802, response due March 26, 2026); and the Texas Health and Human Services Commission's RFI regarding direct-to-manufacturer prescription programs (HHS0017013, posted April 3, 2026). Contract terms typically range from one to two years with renewal options, and suppliers must comply with cGMP certification, DSCSA requirements, specific insurance thresholds, and FDA expiration-date standards.